Nephrotoxicity of contrast media and protective effects of acetylcysteine

Archives of Toxicology

Volumn 85, Issue 3, 2011, Pages 165-173

  Briguori, Carlo ^a   Quintavalle, Cristina ^b   De Micco, Francesca ^c   Condorelli, Gerolama ^d  

^a Clinica Mediterranea   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

Acetylcysteine; Apoptosis; Contrast media; Kidney; NAC

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; FREE RADICAL; IOBITRIDOL; IODIXANOL; IOPROMIDE; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PLACEBO; PROTEIN BCL 2; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; APOPTOSIS; CONCENTRATION RESPONSE; CONTRAST INDUCED NEPHROPATHY; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; GASTROINTESTINAL SYMPTOM; HUMAN; LENGTH OF STAY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REHYDRATION; REVIEW;

EID: 79954417246     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-010-0626-5     Document Type: Review

References (79)

1. JM Adams S Cory 2007 The Bcl-2 apoptotic switch in cancer development and therapy Oncogene 26 9 1234 1237 10.1038/sj.onc.1210220 (Pubitemid 46328466)
2. S Allaqaband R Tumuluri AM Malik A Gupta P Volkert Y Shalev TK Bajwa 2002 Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy Catheter Cardiovasc Interv 57 3 279 283 10.1002/ccd.10323 12410497 (Pubitemid 35266257)
3. A Alonso J Lau BL Jaber A Weintraub MJ Sarnak 2004 Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials Am J Kidney Dis 43 1 1 9 1:CAS:528:DC%2BD2cXht1ehu7c%3D 10.1053/j.ajkd.2003.09.009 14712421 (Pubitemid 38049429)
4. Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F (2009) N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials 10 (45)
5. KJ Andersen EI Christensen H Vik 1994 Effects of iodinated x-ray contrast media on renal epithelial cells in culture Invest Radiol 29 11 955 962 1:STN:280:DyaK2M7pslersQ%3D%3D 10.1097/00004424-199411000-00002 7890510
6. SM Bagshaw FA McAlister BJ Manns WA Ghali 2006 Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence Arch Intern Med 166 2 161 166 1:CAS:528: DC%2BD28XhtFagtLs%3D 10.1001/archinte.166.2.161 16432083 (Pubitemid 43144938)
7. CS Baker A Wragg S Kumar R De Palma LR Baker CJ Knight 2003 A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 12 2114 2118 10.1016/S0735-1097(03)00487-X 12821233 (Pubitemid 36724254)
8. GL Bakris AO Gaber JD Jones 1990 Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium Radiology 175 1 57 60 1:CAS:528:DyaK3cXitlWqtr0%3D 2315505 (Pubitemid 20108540)
9. GL Bakris N Lass AO Gaber JD Jones JCJ Burnett 1990 Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals Am J Physiol 258 1 Pt 2 F115 F120 1:CAS:528:DyaK3cXhtlGhu78%3D 2301588
10. BJ Barrett EJ Carlisle 1993 Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1 171 178 1:STN:280:DyaK3s3ovVylug%3D%3D 8511292 (Pubitemid 23183119)
11. R Beeri Z Symon M Brezis SA Ben-Sasson PH Baehr S Rosen RA Zager 1995 Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys Kidney Int 47 6 1806 1810 1:STN:280:DyaK2MzntFarug%3D%3D 10.1038/ki.1995.249 7543962
12. R Birck S Krzossok F Markowetz P Schnülle FJ van der Woude C Braun 2003 Acetylcysteine for prevention of contrast nephropathy: meta-analysis Lancet 362 9384 598 603 1:CAS:528:DC%2BD3sXms1yitLw%3D 10.1016/S0140-6736(03)14189-X 12944058 (Pubitemid 37013299)
13. F Boccalandro M Amhad RW Smalling S Sdringola 2003 Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheter Cardiovasc Interv 58 3 338 341 10.1002/ccd.10389 (Pubitemid 36259222)
14. C Briguori F Manganelli P Scarpato PP Elia B Golia G Riviezzo S Lepore M Librera B Villari A Colombo B Ricciardelli 2002 Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40 2 298 303 1:CAS:528:DC%2BD38XmtVSksr0%3D 10.1016/S0735-1097(02)01958-7 12106935 (Pubitemid 34756291)
15. C Briguori D Tavano A Colombo 2003 Contrast agent-associated nephrotoxicity Prog Cardiovasc Dis 45 6 493 503 10.1053/pcad.2003.YPCAD16 12800130 (Pubitemid 36666455)
16. C Briguori A Colombo F Airoldi A Violante A Castelli P Balestrieri P Paolo Elia B Golia S Lepore G Riviezzo P Scarpato M Librera A Focaccio B Ricciardelli 2004 N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity J Am Coll Cardiol 44 4 762 765 1:CAS:528:DC%2BD2cXmslegu7w%3D 10.1016/j.jacc.2004.04.052 15312855 (Pubitemid 39099569)
17. C Briguori A Colombo A Violante P Balestrieri F Manganelli P Paolo Elia B Golia S Lepore G Riviezzo P Scarpato A Focaccio M Librera E Bonizzoni B Ricciardelli 2004 Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Eur Heart J 25 3 206 211 1:CAS:528:DC%2BD2cXht1yhs7o%3D 10.1016/j.ehj.2003.11.016 14972420 (Pubitemid 38235156)
18. C Briguori G Visconti NV Rivera A Focaccio B Golia R Giannone D Castaldo F De Micco B Ricciardelli A Colombo 2010 Cystatin C and contrast-induced acute kidney injury Circulation 121 19 2117 2122 1:CAS:528:DC%2BC3cXmtFOis7Y%3D 10.1161/CIRCULATIONAHA.109.919639 20439784
19. LC Coyle A Rodriguez RE Jeschke A Simon-Lee KC Abbott AJ Taylor 2006 Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics Am Heart J 151 5 1032.e9 1032.e12 10.1016/j.ahj.2006.02.002
20. LJ Diaz-Sandoval BD Kosowsky DW Losordo 2002 Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial) Am J Cardiol 89 3 356 358 1:CAS:528:DC%2BD38Xms1Gksg%3D%3D 10.1016/S0002-9149(01)02243-3 11809444 (Pubitemid 34113804)
21. J DiMari J Megyesi N Udvarhelyi P Price R Davis R Safirstein 1997 N-acetyl cysteine ameliorates ischemic renal failure Am J Physiol 272 3 Pt 2 F292 F298 1:CAS:528:DyaK2sXit1Wntbk%3D 9087670
22. LF Drager L Andrade JF Barros de Toledo FR Laurindo LA Machado César AC Seguro 2004 Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury Nephrol Dial Transpl 19 7 1803 1807 1:CAS:528:DC%2BD2cXltVWksrs%3D 10.1093/ndt/gfh261 (Pubitemid 38961391)
23. JD Durham C Caputo J Dokko T Zaharakis M Pahlavan J Keltz P Dutka K Marzo JK Maesaka S Fishbane 2002 A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography Kidney Int 62 6 2202 2207 1:CAS:528:DC%2BD38XpsFKlurg%3D 10.1046/j.1523-1755.2002.00673.x 12427146 (Pubitemid 35366176)
24. S Efrati S Berman Y Siman-Tov R Lotan Z Averbukh J Weissgarten A Golik 2007 N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis Nephrol Dial Transpl 22 7 1873 1881 1:CAS:528:DC%2BD2sXos12htLw%3D 10.1093/ndt/gfm113 (Pubitemid 47244755)
25. S Fishbane JH Durham K Marzo M Rudnick 2004 N-acetylcysteine in the prevention of radiocontrast-induced nephropathy J Am Soc Nephrol 15 2 251 260 1:CAS:528:DC%2BD2cXhtV2iur4%3D 10.1097/01.ASN.0000107562.68920.92 14747371 (Pubitemid 38140765)
26. I Goldenberg M Shechter S Matetzky M Jonas M Adam H Pres D Elian O Agranat E Schwammenthal V Guetta 2004 Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature Eur Heart J 25 3 212 218 1:CAS:528:DC%2BD2cXht1yhs7s%3D 10.1016/j.ehj.2003.11.011 14972421 (Pubitemid 38235157)
27. VO Gomes CE Poli de Figueredo P Caramori R Lasevitch LC Bodanese A Araújo AP Röedel AP Caramori FSJ Brito HG Bezerra P Nery A Brizolara 2005 N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial Heart 91 6 774 778 1:CAS:528:DC%2BD2MXlslCltrc%3D 10.1136/hrt.2004.039636 15894775 (Pubitemid 40769223)
28. DA Gonzales KJ Norsworthy SJ Kern S Banks PC Sieving RA Star C Natanson RL Danner 2007 A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 5 32 10.1186/1741-7015-5-32 18001477
29. MC Heinrich MK Kuhlmann A Grgic M Heckmann B Kramann M Uder 2005 Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro Radiology 253 3 843 849 10.1148/radiol.2353040726 (Pubitemid 40695879)
30. SN Heyman M Goldfarb A Shina F Karmeli S Rosen 2003 N-acetylcysteine ameliorates renal microcirculation: studies in rats Kidney Int 63 2 634 641 1:CAS:528:DC%2BD3sXht1yrtrk%3D 10.1046/j.1523-1755.2003.00783.x 12631128 (Pubitemid 36126809)
31. I Hizoh J Strater CS Schick W Kubler C Haller 1998 Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity Nephrol Dial Transpl 13 4 911 918 1:STN:280:DyaK1c3islyjsQ%3D%3D 10.1093/ndt/13.4.911 (Pubitemid 28161763)
32. H Ichijo 1999 From receptors to stress-activated MAP kinases Oncogene 18 45 6087 6093 1:CAS:528:DyaK1MXns1Oqsrs%3D 10.1038/sj.onc.1203129 10557099
33. YT Ip RJ Davis 1998 Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development Curr Opin Cell Biol 10 2 205 219 1:CAS:528:DyaK1cXisFyntLo%3D 10.1016/S0955-0674(98)80143-9 9561845 (Pubitemid 28174763)
34. DW Isenbarger SM Kent PG O'Malley 2003 Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy Am J cardiol 92 12 1454 1458 1:CAS:528:DC%2BD3sXps1Gru74%3D 10.1016/j.amjcard.2003.08.059 14675586 (Pubitemid 37532572)
35. SH Jo BK Koo JS Park HJ Kang YJ Kim HL Kim IH Chae DJ Choi DW Sohn BH Oh YB Park YS Choi HS Kim 2009 N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial Am Heart J 157 3 576 583 1:CAS:528:DC%2BD1MXisVOlt7g%3D 10.1016/j.ahj.2008.11.010 19249432
36. RE Katholi WTJ Woods GJ Taylor CL Deitrick KA Womack CR Katholi WP McCann 1998 Oxygen free radicals and contrast nephropathy Am J Kidney Dis 32 1 64 71 1:STN:280:DyaK1czjt1Sruw%3D%3D 10.1053/ajkd.1998.v32.pm9669426 9669426 (Pubitemid 28311873)
37. J Kay WH Chow TM Chan SK Lo OH Kwok A Yip K Fan CH Lee WF Lam 2003 Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 5 553 558 1:CAS:528:DC%2BD3sXptVansw%3D%3D 10.1001/jama.289.5.553 12578487 (Pubitemid 37428626)
38. AM Kelly B Dwamena P Cronin SJ Bernstein RC Carlos 2008 Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 4 284 294 18283206 (Pubitemid 351665489)
39. G Kroemer 1999 Mitochondrial control of apoptosis: an overview Biochem Soc Symp 66 1 15 1:CAS:528:DC%2BD3cXkvVOmtg%3D%3D 10989652 (Pubitemid 129639017)
40. AV Kshirsagar C Poole A Mottl D Shoham N Franceschini G Tudor M Agrawal C Denu-Ciocca E Magnus Ohman WF Finn 2004 N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 3 761 769 1:CAS:528:DC%2BD2cXhtlShu70%3D 10.1097/01.ASN.0000116241.47678.49 14978179 (Pubitemid 38294807)
41. JM Kyriakis J Avruch 2001 Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2 807 869 1:CAS:528:DC%2BD3MXislCrsb8%3D 11274345 (Pubitemid 32267078)
42. JM Kyriakis P Banerjee E Nikolakaki T Dai EA Rubie MF Ahmad J Avruch JR Woodgett 1994 The stress-activated protein kinase subfamily of c-Jun kinases Nature 369 6476 156 160 1:CAS:528:DyaK2cXksFWhtb8%3D 10.1038/369156a0 8177321 (Pubitemid 24153440)
43. K Lei RJ Davis 2003 JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis Proc Natl Acad Sci USA 100 5 2432 2437 1:CAS:528:DC%2BD3sXitVaisr8%3D 10.1073/pnas.0438011100 12591950 (Pubitemid 36297516)
44. G Marenzi E Assanelli I Marana G Lauri J Campodonico M Grazi M De Metrio S Galli F Fabbiocchi P Montorsi F Veglia AL Bartorelli 2006 N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 26 2773 2782 1:CAS:528:DC%2BD28XmsVKrur0%3D 10.1056/NEJMoa054209 16807414 (Pubitemid 43974195)
45. PA McCullough 2008 Contrast-induced acute kidney injury JAMA 51 15 1419 1428 (Pubitemid 351471786)
46. A Mehta CPS Sekhon S Giri JK Orak AK Singh 2002 Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon Mol Cell Biochem 240 1 19 29 1:CAS:528:DC%2BD38XnvVegsLY%3D 10.1023/A:1020675721351 12487368 (Pubitemid 35385817)
47. SE Miner V Dzavik P Nguyen-Ho R Richardson J Mitchell D Atchison P Seidelin P Daly J Ross PR McLaughlin D Ing P Lewycky A Barolet L Schwartz 2004 N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 148 4 690 695 1:CAS:528: DC%2BD2cXot1Wksro%3D 10.1016/j.ahj.2004.05.015 15459602 (Pubitemid 39349390)
48. BK Nallamothu KG Shojania S Saint TP Hofer HD Humes M Moscucci ER Bates 2004 Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis Am J Med 117 12 938 947 1:CAS:528:DC%2BD2MXjsVag 10.1016/j.amjmed.2004.06.046 15629733 (Pubitemid 40075562)
49. JB Oldemeyer WP Biddle RL Wurdeman AN Mooss E Cichowski DE Hilleman 2003 Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography Am Heart J 146 6 E23 10.1016/S0002-8703(03)00511-8 14661012
50. EE Ozcan S Guneri B Akdeniz IZ Akyildiz O Senaslan N Baris O Aslan O Badak 2007 Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial Am Heart J 154 3 539 544 1:CAS:528:DC%2BD2sXpsFKqtbY%3D 10.1016/j.ahj.2007.05.012 17719303 (Pubitemid 47268251)
51. N Pannu B Manns H Lee M Tonelli 2004 Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 4 1366 1374 1:CAS:528:DC%2BD2cXjtF2jsr8%3D 10.1111/j.1523-1755.2004.00516.x 15086476 (Pubitemid 38406975)
52. N Pannu N Wiebe M Tonelli AKD Network 2006 Prophylaxis strategies for contrast-induced nephropathy JAMA 295 23 2765 2779 1:CAS:528: DC%2BD28XmtFOlurw%3D 10.1001/jama.295.23.2765 16788132
53. PB Persson M Tepel 2006 Contrast medium-induced nephropathy: the pathophysiology Kidney Int Suppl 100 S8 S10 1:CAS:528:DC%2BD28XktVGlu78%3D 10.1038/sj.ki.5000367 16612403
54. T Rehman J Fought R Solomon 2008 N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients Clin J Am Soc Nephrol 3 6 1610 1614 1:CAS:528:DC%2BD1cXhsVKmsLnN 10.2215/CJN.01560408 18667743
55. SJ Riedl GS Salvesen 2007 The apoptosome: signalling platform of cell death Nat Rev Mol Cell Biol 8 5 405 413 1:CAS:528:DC%2BD2sXksFSjsr4%3D 10.1038/nrm2153 17377525 (Pubitemid 46643237)
56. MJ Robinson MH Cobb 1997 Mitogen-activated protein kinase pathways Curr Opin Cell Biol 9 2 180 186 1:CAS:528:DyaK2sXisVWntLk%3D 10.1016/S0955-0674(97) 80061-0 9069255 (Pubitemid 27135985)
57. G Romano C Briguori C Quintavalle C Zanca NV Rivera A Colombo G Condorelli 2008 Contrast agents and renal cell apoptosis Eur Hearth J 29 20 2569 2576 1:CAS:528:DC%2BD1cXhsVSjur7P 10.1093/eurheartj/ehn197
58. RR Rosato JA Almenara Y Dai S Grant 2003 Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells Mol Cancer Ther 2 12 1273 1284 1:CAS:528:DC%2BD2cXnvFSr 14707268
59. A Saleh SM Srinivasula S Acharya R Fishel ES Alnemri 1999 Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation J Biol Chem 274 25 17941 17945 1:CAS:528:DyaK1MXktVylsb8%3D 10.1074/jbc.274.25.17941 10364241 (Pubitemid 29283318)
60. F Sar T Saler A Ecebay ZA Saglam S Ozturk R Kazancioglu 2010 The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy J Nephrol 23 4 478 482 20383874
61. CG Schnackenberg 2002 Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature Am J Physiol Regul Integr Comp Physiol 282 2 R335 R342 1:CAS:528:DC%2BD38XhtFCqtbs%3D 11792641
62. SJ Schwab MA Hlatky KS Pieper CJ Davidson KG Morris TN Skelton TM Bashore 1989 Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent N Engl J Med 320 3 149 153 1:STN:280:DyaL1M%2FpslWjug%3D%3D 10.1056/NEJM198901193200304 2643042 (Pubitemid 19033092)
63. SJ Shah CY Hsu 2004 Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study Am Heart J 117 12 948 952 (Pubitemid 40075563)
64. SJ Shalansky GE Pate A Levin JG Webb 2005 N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration Hearth 91 8 997 999 1:CAS:528:DC%2BD2MXps1Cku70%3D 10.1136/hrt.2004.053579 (Pubitemid 41059998)
65. KG Shyu JJ Cheng P Kuan 2002 Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 8 1383 1388 1:CAS:528:DC%2BD38XovVGktbY%3D 10.1016/S0735-1097(02)02308-2 12392825 (Pubitemid 35192860)
66. EP Steinberg RD Moore NR Powe R Gopalan AJ Davidoff M Litt S Graziano JA Brinker 1992 Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography N Engl J Med 328 7 425 430 10.1056/NEJM199202133260701
67. A Strasser L O'Connor VM Dixit 2000 Apoptosis signaling Annu Rev Biochem 69 217 245 1:CAS:528:DC%2BD3cXnt1ajtLY%3D 10.1146/annurev.biochem.69.1.217 10966458
68. T Tanaka T Miyata R Inagi K Kurokawa S Adler T Fujita M Nangaku 2003 Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways Kidney Int 64 6 2020 2032 1:CAS:528: DC%2BD3sXpvFOqsrk%3D 10.1046/j.1523-1755.2003.00301.x 14633124 (Pubitemid 37449536)
69. M Tariq C Morais S Sobki M Al Sulaiman A Al Khader 1999 N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats Nephrol Dial Transpl 14 4 923 929 1:CAS:528:DyaK1MXislOgsbo%3D 10.1093/ndt/14.4.923 (Pubitemid 29155148)
70. M Tepel M van der Giet C Schwarzfeld U Laufer D Liermann W Zidek 2000 Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 3 180 184 1:CAS:528:DC%2BD3cXlsF2jsrs%3D 10.1056/NEJM200007203430304 10900277 (Pubitemid 30489215)
71. Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G (2009) High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 122(9):874.e9-874.e15
72. J Tumlin F Stacul A Adam CR Becker C Davidson N Lameire PA McCullough CCW Panel 2006 Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 6A 14K 20K 1:CAS:528:DC%2BD28XhtVyqurbF 10.1016/j.amjcard.2006.01.020 16949376 (Pubitemid 44292090)
73. S Wang WS El-Deiry 2003 TRAIL and apoptosis induction by TNF-family death receptors Oncogene 22 53 8628 8633 1:CAS:528:DC%2BD3sXptFOmur4%3D 10.1038/sj.onc.1207232 14634624 (Pubitemid 38019198)
74. JG Webb GE Pate KH Humphries CE Buller S Shalansky A Al Shamari A Sutander T Williams RS Fox A Levin 2004 A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 3 422 429 1:CAS:528:DC%2BD2cXnvVOju7s%3D 10.1016/j.ahj.2004.03.041 15389228 (Pubitemid 39265114)
75. E Yang SJ Korsmeyer 1996 Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood 88 2 386 401 1:CAS:528:DyaK28XktFSrtLc%3D 8695785 (Pubitemid 26240369)
76. T Yano Y Itoh T Sendo T Kubota R Oishi 2003 Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase Kidney Int 64 6 2052 2063 1:CAS:528:DC%2BD3sXpvFOqs78%3D 10.1046/j.1523-1755.2003.00335.x 14633127 (Pubitemid 37449539)
77. RA Zager AC Johnson SY Hanson 2003 Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity Kidney Int 64 1 128 139 1:CAS:528:DC%2BD3sXlsFelu7c%3D 10.1046/j.1523-1755.2003. 00059.x 12787403 (Pubitemid 36714165)
78. A Zagler M Azadpour C Mercado CH Hennekens 2006 N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials Am Heart J 151 1 140 145 1:CAS:528:DC%2BD2MXhtlGisLjK 10.1016/j.ahj.2005.01.055 16368307 (Pubitemid 41815344)
79. L Zhu P He 2005 Platelet-activating factor increases endothelial [Ca2+] i and NO production in individually perfused intact microvessels Am J Physiol Heart Circ Physiol 288 6 H2869 H2877 1:CAS:528:DC%2BD2MXlsVyntLk%3D 10.1152/ajpheart.01080.2004 15665052 (Pubitemid 40720669)